Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility studyD Schrijvers, C Van Herpen, J Kerger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 10, 2013
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trialE de Azambuja, D Zardavas, M Lemort, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 9, 2022
Streamlining clinical research: an ESMO awareness call to improve sponsoring and monitoring of clinical trialsJ L Perez-Gracia, N Penel, E Calvo, et al.
ESMO Open|April 9, 2025
Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphomaU M Lauer, A Awada, S Postel-Vinay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industryR Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 28, 2017
Evaluation of the impact of tumor HPV status on outcome in patients with locally advanced unresectable head and neck squamous cell carcinoma (HNSCC) receiving cisplatin, 5-fluorouracil with or without docetaxel: a subset analysis of EORTC 24971 studyA Psyrri, C Fortpied, G Koutsodontis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2018
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 studyS Adams, P Schmid, H S Rugo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trialG Gebhart, L E Lamberts, Z Wimana, et al.
ESMO Open|August 15, 2022
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignmentJ Thouvenin, C Van Marcke, L Decoster, et al.
Pageof 20